Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alexion Pharmaceuticals, Inc. (ALXN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alexion Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 899866.
Total stock buying since 2014: $437,497,430.
Total stock sales since 2014: $412,169,334.
Total stock option exercises since 2014: $47,629,632.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 550,902 | $43,418,749 | 32,449 | $4,771,020 | 24,066 | $2,860,725 |
| 2019 | 0 | $0 | 307,078 | $38,012,774 | 0 | $0 |
| 2018 | 10,000 | $1,207,900 | 59,447 | $6,969,140 | 0 | $0 |
| 2017 | 3,370,689 | $392,775,613 | 127,460 | $17,202,952 | 59,329 | $2,198,385 |
| 2016 | 0 | $0 | 124,312 | $17,235,284 | 53,449 | $2,891,440 |
| 2015 | 0 | $0 | 498,689 | $91,579,256 | 203,500 | $11,185,104 |
| 2014 | 510 | $95,168 | 1,361,896 | $236,398,908 | 1,216,245 | $28,493,978 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-12 | 0 | $0 | 25,596 | $3,984,262 | 24,066 | $2,860,725 |
| 2020-06 | 0 | $0 | 6,853 | $786,758 | 0 | $0 |
| 2020-03 | 550,902 | $43,418,749 | 0 | $0 | 0 | $0 |
| 2019-07 | 0 | $0 | 4,500 | $597,510 | 0 | $0 |
| 2019-06 | 0 | $0 | 578 | $76,296 | 0 | $0 |
| 2019-05 | 0 | $0 | 300,000 | $37,086,968 | 0 | $0 |
| 2019-02 | 0 | $0 | 2,000 | $252,000 | 0 | $0 |
| 2018-12 | 0 | $0 | 3,244 | $310,937 | 0 | $0 |
| 2018-11 | 0 | $0 | 2,605 | $307,728 | 0 | $0 |
| 2018-07 | 0 | $0 | 5,241 | $687,147 | 0 | $0 |
| 2018-06 | 0 | $0 | 7,088 | $840,137 | 0 | $0 |
| 2018-04 | 10,000 | $1,207,900 | 0 | $0 | 0 | $0 |
| 2018-02 | 0 | $0 | 38,716 | $4,512,670 | 0 | $0 |
| 2018-01 | 0 | $0 | 2,553 | $310,521 | 0 | $0 |
| 2017-10 | 0 | $0 | 120 | $16,800 | 0 | $0 |
| 2017-09 | 0 | $0 | 4,598 | $671,393 | 0 | $0 |
| 2017-08 | 0 | $0 | 11,772 | $1,649,304 | 0 | $0 |
| 2017-07 | 0 | $0 | 700 | $96,418 | 0 | $0 |
| 2017-06 | 3,370,689 | $392,775,613 | 835 | $97,511 | 0 | $0 |
| 2017-03 | 0 | $0 | 3,103 | $411,993 | 0 | $0 |
| 2017-02 | 0 | $0 | 43,508 | $5,575,237 | 0 | $0 |
| 2017-01 | 0 | $0 | 62,824 | $8,684,296 | 59,329 | $2,198,385 |
| 2016-12 | 0 | $0 | 3,352 | $423,868 | 0 | $0 |
| 2016-11 | 0 | $0 | 37,376 | $5,253,261 | 36,649 | $839,262 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-17 | Bazarko Daniel (SVP, Controller, CAO) | Sale | 24,066 | 157.78 | 3,797,205 |
| 2020-12-17 | Bazarko Daniel (SVP, Controller, CAO) | Option Ex | 24,066 | 118.87 | 2,860,725 |
| 2020-12-03 | Carino Tanisha (EVP & CCAO) | Sale | 1,530 | 122.26 | 187,057 |
| 2020-06-08 | Franchini Indrani Lall (EVP, Chief Compliance Officer) | Sale | 6,853 | 114.81 | 786,758 |
| 2020-03-18 | Baker Julian (Director) | Buy | 132,281 | 80.94 | 10,741,851 |
| 2020-03-17 | Baker Julian (Director) | Buy | 102,421 | 77.14 | 7,901,063 |
| 2020-03-16 | Baker Julian (Director) | Buy | 265,298 | 78.08 | 20,714,467 |
| 2019-07-01 | Franchini Indrani Lall (EVP, Chief Compliance Officer) | Sale | 4,500 | 132.78 | 597,510 |
| 2019-06-21 | Sarin Aradhana (Chief Strategy & Business Officer) | Sale | 578 | 132.00 | 76,296 |
| 2019-05-30 | Baker Julian (Director) | Sale | 57,449 | 121.07 | 6,955,178 |
| 2019-05-29 | Baker Julian (Director) | Sale | 119,062 | 122.27 | 14,557,234 |
| 2019-05-28 | Baker Julian (Director) | Sale | 123,489 | 126.12 | 15,574,556 |
| 2019-02-14 | Bazarko Daniel (SVP, Controller, CAO) | Sale | 2,000 | 126.00 | 252,000 |
| 2018-12-31 | Hantson Ludwig (CEO) | Sale | 3,244 | 95.85 | 310,937 |
| 2018-11-28 | Franchini Indrani Lall (EVP, Chief Compliance Officer) | Sale | 2,605 | 118.13 | 307,728 |
| 2018-07-10 | Clancy Paul J (EVP, Chief Financial Officer) | Sale | 5,241 | 131.11 | 687,147 |
| 2018-06-08 | Franchini Indrani Lall (EVP, Chief Compliance Officer) | Sale | 1,466 | 118.53 | 173,764 |
| 2018-06-08 | Orloff John J (EVP, Research & Development) | Sale | 2,115 | 118.53 | 250,690 |
| 2018-06-08 | Goff Brian (EVP & Chief Commercial Officer) | Sale | 1,645 | 118.53 | 194,981 |
| 2018-06-08 | Law Anne-marie (EVP and CHRO) | Sale | 1,862 | 118.53 | 220,702 |
| 2018-04-30 | Coughlin Christopher J | Buy | 10,000 | 120.79 | 1,207,900 |
| 2018-02-28 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 454 | 118.61 | 53,848 |
| 2018-02-28 | O'neill Julie (EVP. Global Operations) | Sale | 686 | 118.61 | 81,366 |
| 2018-02-27 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 244 | 120.72 | 29,455 |
| 2018-02-27 | O'neill Julie (EVP. Global Operations) | Sale | 939 | 120.72 | 113,356 |
| 2018-02-08 | Franchini Indrani Lall (EVP, Chief Compliance Officer) | Sale | 1,459 | 116.31 | 169,696 |
| 2018-02-08 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 1,774 | 116.31 | 206,333 |
| 2018-02-08 | O'neill Julie (EVP. Global Operations) | Sale | 4,787 | 116.31 | 556,775 |
| 2018-02-08 | Moriarty John B (EVP & General Counsel) | Sale | 3,363 | 115.70 | 389,099 |
| 2018-02-08 | Goff Brian (EVP & Chief Commercial Officer) | Sale | 1,651 | 116.31 | 192,027 |
| 2018-02-08 | Hantson Ludwig (CEO) | Sale | 13,245 | 116.31 | 1,540,525 |
| 2018-02-08 | Clancy Paul J (EVP, Chief Financial Officer) | Sale | 6,079 | 116.31 | 707,048 |
| 2018-02-05 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 655 | 117.26 | 76,805 |
| 2018-02-05 | O'neill Julie (EVP. Global Operations) | Sale | 2,119 | 117.26 | 248,473 |
| 2018-02-05 | Moriarty John B (EVP & General Counsel) | Sale | 1,261 | 117.26 | 147,864 |
| 2018-01-02 | Hantson Ludwig (CEO) | Sale | 2,553 | 121.63 | 310,521 |
| 2017-10-02 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 120 | 140.00 | 16,800 |
| 2017-09-05 | O'neill Julie (EVP. Global Operations) | Sale | 3,763 | 146.06 | 549,642 |
| 2017-09-05 | Veneman Ann M | Sale | 835 | 145.81 | 121,751 |
| 2017-08-31 | O'neill Julie (EVP. Global Operations) | Sale | 612 | 142.00 | 86,904 |
| 2017-08-28 | O'neill Julie (EVP. Global Operations) | Sale | 11,160 | 140.00 | 1,562,400 |
| 2017-07-31 | Veneman Ann M | Sale | 700 | 137.74 | 96,418 |
| 2017-06-15 | Baker Brothers Life Sciences Lp (Director) | Buy | 656,387 | 117.05 | 76,832,723 |
| 2017-06-15 | Parven Alvin S | Sale | 835 | 116.78 | 97,511 |
| 2017-06-15 | Coughlin Christopher J | Buy | 2,000 | 117.10 | 234,200 |
| 2017-06-14 | Hantson Ludwig (CEO) | Buy | 10,000 | 116.72 | 1,167,200 |
| 2017-06-14 | Baker Brothers Life Sciences Lp (Director) | Buy | 1,353,347 | 117.20 | 157,529,873 |
| 2017-03-02 | O'neill Julie (EVP. Global Operations) | Sale | 651 | 133.80 | 87,103 |
| 2017-03-01 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 156 | 132.50 | 20,670 |
| 2017-03-01 | Moriarty John B (EVP & General Counsel) | Sale | 282 | 132.50 | 37,365 |
| 2017-03-01 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 404 | 132.50 | 53,530 |
| 2017-03-01 | Mackay Martin (EVP & Global Head of R&D) | Sale | 370 | 132.50 | 49,025 |
| 2017-03-01 | Bell Leonard | Sale | 1,240 | 132.50 | 164,300 |
| 2017-02-28 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 480 | 131.70 | 63,215 |
| 2017-02-28 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 3,837 | 65.50 | 495,610 |
| 2017-02-28 | O'neill Julie (EVP. Global Operations) | Sale | 664 | 131.70 | 87,448 |
| 2017-02-28 | Miller Edward (SVP, Chief Compliance Officer) | Sale | 330 | 131.70 | 43,460 |
| 2017-02-28 | Moriarty John B (EVP & General Counsel) | Sale | 910 | 131.71 | 119,856 |
| 2017-02-28 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 915 | 131.71 | 120,514 |
| 2017-02-28 | Mackay Martin (EVP & Global Head of R&D) | Sale | 625 | 131.70 | 82,312 |
| 2017-02-28 | Bell Leonard | Sale | 2,738 | 131.71 | 360,621 |
| 2017-02-27 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 358 | 131.20 | 46,969 |
| 2017-02-27 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 71 | 131.20 | 9,315 |
| 2017-02-27 | O'neill Julie (EVP. Global Operations) | Sale | 910 | 131.20 | 119,391 |
| 2017-02-27 | Miller Edward (SVP, Chief Compliance Officer) | Sale | 260 | 131.20 | 34,112 |
| 2017-02-27 | Moriarty John B (EVP & General Counsel) | Sale | 612 | 131.20 | 80,294 |
| 2017-02-27 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 860 | 131.20 | 112,831 |
| 2017-02-27 | Mackay Martin (EVP & Global Head of R&D) | Sale | 860 | 131.20 | 112,831 |
| 2017-02-09 | Moriarty John B (EVP & General Counsel) | Sale | 167 | 126.84 | 21,182 |
| 2017-02-09 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 167 | 126.84 | 21,182 |
| 2017-02-09 | Mackay Martin (EVP & Global Head of R&D) | Sale | 217 | 126.84 | 27,524 |
| 2017-02-09 | Bell Leonard | Sale | 246 | 126.84 | 31,202 |
| 2017-02-07 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 222 | 128.09 | 28,435 |
| 2017-02-07 | Moriarty John B (EVP & General Counsel) | Sale | 135 | 128.09 | 17,292 |
| 2017-02-07 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 166 | 128.09 | 21,262 |
| 2017-02-07 | Bell Leonard | Sale | 1,010 | 128.09 | 129,370 |
| 2017-02-06 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 1,710 | 125.86 | 215,229 |
| 2017-02-06 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 165 | 125.69 | 20,738 |
| 2017-02-06 | O'neill Julie (EVP. Global Operations) | Sale | 2,795 | 125.69 | 351,303 |
| 2017-02-06 | Miller Edward (SVP, Chief Compliance Officer) | Sale | 1,045 | 126.32 | 132,004 |
| 2017-02-06 | Moriarty John B (EVP & General Counsel) | Sale | 3,403 | 126.03 | 428,897 |
| 2017-02-06 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 3,404 | 126.17 | 429,482 |
| 2017-02-06 | Mackay Martin (EVP & Global Head of R&D) | Sale | 2,728 | 126.28 | 344,505 |
| 2017-02-06 | Bell Leonard | Sale | 7,715 | 125.89 | 971,241 |
| 2017-01-10 | Bell Leonard | Sale | 100 | 144.99 | 14,499 |
| 2017-01-10 | Bell Leonard | Option Ex | 100 | 22.90 | 2,290 |
| 2017-01-09 | Bell Leonard | Sale | 5,187 | 144.91 | 751,674 |
| 2017-01-09 | Bell Leonard | Option Ex | 4,853 | 22.90 | 111,133 |
| 2017-01-05 | Parven Alvin S | Sale | 22,659 | 137.86 | 3,123,724 |
| 2017-01-05 | Parven Alvin S | Option Ex | 20,166 | 64.54 | 1,301,553 |
| 2017-01-05 | Bell Leonard | Sale | 34,878 | 137.46 | 4,794,399 |
| 2017-01-05 | Bell Leonard | Option Ex | 34,210 | 22.90 | 783,409 |
| 2016-12-12 | Moriarty John B (EVP & General Counsel) | Sale | 1,044 | 118.61 | 123,828 |
| 2016-12-09 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 2,308 | 130.00 | 300,040 |
| 2016-11-14 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 59 | 115.10 | 6,790 |
| 2016-11-04 | Bell Leonard | Sale | 37,317 | 140.59 | 5,246,471 |
| 2016-11-04 | Bell Leonard | Option Ex | 36,649 | 22.90 | 839,262 |
| 2016-10-31 | Bell Leonard | Sale | 1,634 | 135.32 | 221,121 |
| 2016-10-31 | Bell Leonard | Option Ex | 1,300 | 22.90 | 29,769 |
| 2016-10-14 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 4,584 | 120.28 | 551,363 |
| 2016-10-03 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 120 | 122.41 | 14,689 |
| 2016-10-03 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 29 | 122.41 | 3,549 |
| 2016-09-23 | Norby R Douglas | Option Ex | 15,500 | 130.48 | 2,022,409 |
| 2016-09-13 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 3,000 | 129.00 | 387,000 |
| 2016-09-12 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 225 | 124.20 | 27,945 |
| 2016-09-09 | Miller Edward (SVP, Chief Compliance Officer) | Sale | 367 | 128.32 | 47,093 |
| 2016-09-06 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 1,000 | 125.94 | 125,940 |
| 2016-09-02 | O'neill Julie (EVP. Global Operations) | Sale | 650 | 126.29 | 82,088 |
| 2016-08-30 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 1,000 | 127.76 | 127,760 |
| 2016-08-08 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 222 | 137.14 | 30,445 |
| 2016-08-08 | Moriarty John B (EVP & General Counsel) | Sale | 135 | 137.14 | 18,513 |
| 2016-08-08 | Hallal David (CEO) | Sale | 332 | 137.14 | 45,530 |
| 2016-08-08 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 165 | 137.14 | 22,628 |
| 2016-08-08 | Sinha Vikas (EVP & CFO) | Sale | 277 | 137.14 | 37,987 |
| 2016-08-08 | Bell Leonard | Sale | 1,010 | 137.14 | 138,511 |
| 2016-06-13 | Moriarty John B (EVP & General Counsel) | Sale | 918 | 135.72 | 124,590 |
| 2016-05-16 | Mackay Martin (EVP & Global Head of R&D) | Sale | 4,097 | 139.81 | 572,801 |
| 2016-05-13 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 53 | 138.65 | 7,348 |
| 2016-04-01 | Hallal David (CEO) | Sale | 1,414 | 136.04 | 192,360 |
| 2016-03-02 | O'neill Julie (EVP. Global Operations) | Sale | 651 | 149.55 | 97,357 |
| 2016-02-29 | O'neill Julie (EVP. Global Operations) | Sale | 663 | 138.91 | 92,097 |
| 2016-02-29 | Hallal David (CEO) | Sale | 2,014 | 140.18 | 282,322 |
| 2016-02-29 | Mackay Martin (EVP & Global Head of R&D) | Sale | 1,000 | 138.91 | 138,910 |
| 2016-02-29 | Sinha Vikas (EVP & CFO) | Sale | 1,122 | 140.07 | 157,158 |
| 2016-02-16 | Thiel Carsten (EVP, Chief Commercial Officer) | Sale | 187 | 143.49 | 26,832 |
| 2016-02-08 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 942 | 138.63 | 130,586 |
| 2016-02-08 | O'neill Julie (EVP. Global Operations) | Sale | 778 | 138.88 | 108,052 |
| 2016-02-08 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 1,474 | 138.90 | 204,731 |
| 2016-02-08 | Moriarty John B (EVP & General Counsel) | Sale | 2,633 | 138.75 | 365,328 |
| 2016-02-08 | Hallal David (CEO) | Sale | 3,946 | 138.41 | 546,154 |
| 2016-02-08 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 2,665 | 138.39 | 368,809 |
| 2016-02-08 | Mackay Martin (EVP & Global Head of R&D) | Sale | 1,966 | 139.17 | 273,608 |
| 2016-02-08 | Sinha Vikas (EVP & CFO) | Sale | 3,890 | 136.42 | 530,685 |
| 2016-02-08 | Bell Leonard | Sale | 11,474 | 138.79 | 1,592,510 |
| 2016-02-05 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 997 | 143.40 | 142,967 |
| 2016-02-05 | O'neill Julie (EVP. Global Operations) | Sale | 2,080 | 143.48 | 298,442 |
| 2016-02-05 | Miller Edward (SVP, Chief Compliance Officer) | Sale | 1,051 | 143.34 | 150,648 |
| 2016-02-05 | Islam Saqib (EVP, Chief Strat & Port. Off.) | Sale | 1,970 | 143.95 | 283,585 |
| 2016-02-05 | Moriarty John B (EVP & General Counsel) | Sale | 1,969 | 143.41 | 282,366 |
| 2016-02-05 | Hallal David (CEO) | Sale | 6,722 | 142.86 | 960,291 |
| 2016-02-05 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 1,993 | 142.88 | 284,765 |
| 2016-02-05 | Mackay Martin (EVP & Global Head of R&D) | Sale | 2,105 | 142.87 | 300,747 |
| 2016-02-05 | Sinha Vikas (EVP & CFO) | Sale | 1,954 | 143.92 | 281,213 |
| 2016-02-05 | Bell Leonard | Sale | 2,136 | 142.93 | 305,298 |
| 2016-02-04 | Wagner Heidi L (SVP, Global Government Affairs) | Sale | 169 | 144.60 | 24,438 |
| 2016-02-04 | Hallal David (CEO) | Sale | 629 | 144.43 | 90,846 |
| 2016-02-04 | Carmichael Clare (EVP, Chief HR Officer) | Sale | 207 | 144.47 | 29,905 |
| 2016-02-04 | Sinha Vikas (EVP & CFO) | Sale | 703 | 144.60 | 101,657 |
| 2016-02-04 | Bell Leonard | Sale | 2,262 | 144.38 | 326,587 |
| 2015-12-29 | Bell Leonard | Sale | 28,968 | 190.84 | 5,528,397 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALXN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alexion Pharmaceuticals, Inc. (symbol ALXN, CIK number 899866) see the Securities and Exchange Commission (SEC) website.